To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene FADS1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
436 supporting clones for gene FADS1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA918413 small intestine .a 1 to 390 2 to 392   tiling clone, capped   391/391
(100 %)
2 diff
(99.5 %id)
BP253788 Kidney .a 79 to 660 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA231492 brain .a 105 to 655 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
NM_013402.4   .a 105 to 4518 1 to 4414 exact RefSeq, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 4414/4414
(100 %)
0 diff
(100 %id)
DA054997 cerebellum .a 130 to 682 2 to 554   tiling clone, capped   553/553
(100 %)
0 diff
(100 %id)
DA774038 brain .a 130 to 387 2 to 259   capped   258/258
(100 %)
0 diff
(100 %id)
BP253945 Kidney .a 154 to 736 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
AK074819   .a 171 to 2250 1 to 2080 F438S K488E available from FLJ,   2080/2080
(100 %)
2 diff
(100.0 %id)
DA607093   .a 172 to 738 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA714863   .a 172 to 690 2 to 520   capped   519/519
(100 %)
0 diff
(100 %id)
DA963779 stomach .a 172 to 723 2 to 564   capped   563/563
(100 %)
14 diff
(97.6 %id)
DA615314   .a 174 to 698 2 to 526   capped   525/525
(100 %)
0 diff
(100 %id)
DR001076 fetal brain .a 175 to 834 9 to 667       659/667
(98 %)
7 diff
(99.0 %id)
AK074754   .a 195 to 2233 30 to 2068 F157L D200E N270S available from FLJ,   2039/2207
(92 %)
11 diff
(99.6 %id)
CR591980 B cells (Ramos cell line) Cot 25-normalized .a 198 to 1838 1 to 1641 exact     1641/1641
(100 %)
0 diff
(100 %id)
CN299565 embryonic stem cells, DMSO-treated H9 cellline .a 204 to 512 1 to 309       309/309
(100 %)
0 diff
(100 %id)
DB473085 hippocampus .a 221 to 684 1 to 464       464/464
(100 %)
0 diff
(100 %id)
DA374302 thalamus .a 232 to 758 2 to 528   capped   527/527
(100 %)
0 diff
(100 %id)
DA838214 placenta .a 244 to 797 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DB098452 testis .a 249 to 817 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DB480052 hippocampus .a 260 to 539 1 to 282       282/297
(94 %)
3 diff
(99.0 %id)
TI_44169282   .a 260 to 1110 86 to 955       867/957
(90 %)
35 diff
(96.4 %id)
DA052031   .a 268 to 574 2 to 308   capped   307/307
(100 %)
0 diff
(100 %id)
DA744842   .a 269 to 849 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
BP305361   .a 270 to 849 1 to 580       580/580
(100 %)
0 diff
(100 %id)
DA756331   .a 271 to 751 2 to 482   capped   481/481
(100 %)
0 diff
(100 %id)
DA984355 synovial membrane tissue from rheumatioidarthritis .a 271 to 834 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
BX414557 thymus .a 272 to 1189 1 to 902       902/915
(98 %)
24 diff
(97.4 %id)
DA698335   .a 273 to 740 2 to 469   capped   468/468
(100 %)
0 diff
(100 %id)
DA678437   .a 280 to 811 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
BU165029 eye, retinoblastoma .a 285 to 1177 1 to 900       896/902
(99 %)
12 diff
(98.7 %id)
AW732381 Kidney, renal cell adenocarcinoma .a 287 to 691 1 to 405       405/405
(100 %)
1 diff
(99.8 %id)
DB504736 hypothalamus .a 294 to 770 1 to 477       477/477
(100 %)
1 diff
(99.8 %id)
BI597155 brain, hypothalamus .a 302 to 1147 1 to 844       844/881
(95 %)
21 diff
(97.7 %id)
BI553751 brain, hippocampus .a 304 to 1149 1 to 846       846/870
(97 %)
40 diff
(95.5 %id)
AK027522   .a 305 to 2250 1 to 1946   available from FLJ,   1946/1946
(100 %)
2 diff
(99.9 %id)
BP281430 bone marrow .a 305 to 922 1 to 618       618/618
(100 %)
0 diff
(100 %id)
DA190431 amygdala .a 306 to 882 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA346781 substantia nigra .a 307 to 866 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DB483628 hippocampus .a 307 to 755 1 to 449       449/449
(100 %)
3 diff
(99.4 %id)
DB488527 hypothalamus .a 307 to 751 1 to 444       444/444
(100 %)
10 diff
(97.8 %id)
DB505745 hypothalamus .a 307 to 814 1 to 508       508/508
(100 %)
2 diff
(99.7 %id)
DA579678   .a 307 to 857 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
TI_44167538   .a 307 to 1029 62 to 781       720/781
(92 %)
14 diff
(98.3 %id)
TI_44168096   .a 307 to 1149 130 to 972       843/996
(84 %)
32 diff
(96.8 %id)
TI_45209766   .a 307 to 814 126 to 633       508/634
(80 %)
9 diff
(98.6 %id)
TI_45212891   .a 307 to 1135 127 to 961       833/961
(86 %)
23 diff
(97.7 %id)
TI_45214969   .a 307 to 1093 88 to 872       785/990
(79 %)
16 diff
(98.4 %id)
TI_45215514   .a 307 to 1147 91 to 929       839/966
(86 %)
21 diff
(97.9 %id)
TI_45216198   .a 307 to 1139 88 to 921       834/990
(84 %)
23 diff
(97.7 %id)
CB135829 Liver .a 307 to 866 1 to 560       560/560
(100 %)
0 diff
(100 %id)
DA367174 subthalamic nucleus .a 308 to 882 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
BP212848 cerebrum .a 308 to 891 1 to 584       584/584
(100 %)
0 diff
(100 %id)
DB460087 testis .a 308 to 782 1 to 475       475/475
(100 %)
1 diff
(99.8 %id)
DB185560 liver, tumor tissue .a 308 to 826 2 to 520   capped   519/519
(100 %)
0 diff
(100 %id)
BP207392 coronary artery .a 309 to 892 1 to 584       584/584
(100 %)
0 diff
(100 %id)
ES307753 beard hair, skin .a 313 to 493 1 to 178       178/178
(100 %)
4 diff
(97.8 %id)
BQ927782 carcinoma, cell line, Prostate .a 314 to 1174 1 to 868       864/872
(99 %)
42 diff
(95.2 %id)
TI_57165169   .a 314 to 1104 25 to 825   AAA   801/888
(90 %)
22 diff
(97.6 %id)
CR597486 Placenta Cot 25-normalized .a 315 to 1844 1 to 1530       1530/1530
(100 %)
0 diff
(100 %id)
BX336198 Placenta Cot 25-normalized .a 315 to 1065 1 to 749   fully sequenced,   749/749
(100 %)
2 diff
(99.8 %id)
BG684057 B-cells, primary B-cells from tonsils (cell line) .a 318 to 1157 1 to 834       834/847
(98 %)
15 diff
(98.3 %id)
BX353249 Neuroblastoma Cot 25-normalized .a 319 to 1144 1 to 825       825/891
(92 %)
31 diff
(96.6 %id)
BG698177 skin .a 319 to 1218 1 to 900       900/954
(94 %)
25 diff
(97.4 %id)
AK314199   .a 321 to 1738 1 to 1418       1418/1418
(100 %)
0 diff
(100 %id)
CA396708 eye, RPE/choroid .a 321 to 777 1 to 457       457/457
(100 %)
0 diff
(100 %id)
DA689172   .a 321 to 847 2 to 528   capped   527/527
(100 %)
0 diff
(100 %id)
DA752563   .a 321 to 877 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA904191   .a 321 to 885 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
AL512760 melanoma (MeWo cell line) .a 324 to 4518 1 to 4196   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 4196/4196
(100 %)
1 diff
(100.0 %id)
AW247099 lung, small cell carcinoma .a 325 to 779 10 to 464       455/464
(98 %)
0 diff
(100 %id)
BQ927565 large cell carcinoma, lung .a 325 to 1147 26 to 852       827/958
(86 %)
26 diff
(97.3 %id)
AF084558   .a 326 to 4523 1 to 4205       4205/4205
(100 %)
10 diff
(99.8 %id)
DA752494   .a 327 to 882 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
BM787409 stomach .a 327 to 882 1 to 556       556/556
(100 %)
0 diff
(100 %id)
DA004477   .a 328 to 906 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA037633   .a 328 to 872 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
CN299569 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 328 to 934 1 to 607       607/607
(100 %)
0 diff
(100 %id)
BI258297 cervical carcinoma cell line, cervix .a 328 to 1147 1 to 824       824/867
(95 %)
13 diff
(98.6 %id)
DA608462   .a 328 to 857 2 to 531   capped   530/530
(100 %)
0 diff
(100 %id)
DA685780   .a 328 to 873 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA902534   .a 328 to 892 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA969342 stomach .a 328 to 883 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
BP267993 thyroid .a 331 to 910 1 to 580       580/580
(100 %)
0 diff
(100 %id)
DA462768   .a 332 to 885 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
CN299570 embryonic stem cells, DMSO-treated H9 cellline .a 338 to 724 1 to 387       387/387
(100 %)
1 diff
(99.8 %id)
BG470429 eye, retinoblastoma .a 338 to 1147 1 to 809       809/826
(97 %)
5 diff
(99.4 %id)
BQ231381 large cell carcinoma, lung .a 340 to 1075 1 to 738       738/929
(79 %)
11 diff
(98.9 %id)
BU182917 melanotic melanoma, skin .a 340 to 1019 1 to 683       683/898
(76 %)
6 diff
(99.4 %id)
BM915614 amelanotic melanoma, cell line, skin .a 341 to 1224 1 to 892       892/1055
(84 %)
12 diff
(98.9 %id)
CR611884 B cells (Ramos cell line) Cot 25-normalized .a 348 to 1868 1 to 1521       1521/1521
(100 %)
0 diff
(100 %id)
BE019069 muscle, rhabdomyosarcoma .a 350 to 691 1 to 342       342/342
(100 %)
1 diff
(99.8 %id)
DA746585   .a 350 to 911 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
BP354396   .a 355 to 936 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BF725218 eye, Iris .a 356 to 852 1 to 497       497/497
(100 %)
0 diff
(100 %id)
AK222906 Kidney .a 361 to 2215 1 to 1855       1855/1855
(100 %)
2 diff
(99.9 %id)
DA910465   .a 361 to 915 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA109312 cerebellum .a 362 to 938 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
BE299880 muscle, rhabdomyosarcoma .a 362 to 1147 1 to 781       781/788
(99 %)
13 diff
(98.4 %id)
DA754814   .a 362 to 896 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
DA247155 brain .a 363 to 959 2 to 598   capped   597/597
(100 %)
0 diff
(100 %id)
BJ991258 hepatoblastoma .a 364 to 948 1 to 585       585/585
(100 %)
1 diff
(99.9 %id)
BP301615   .a 364 to 945 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BG829208 muscle, rhabdomyosarcoma .a 375 to 1167 1 to 798       798/799
(99 %)
11 diff
(98.7 %id)
BP380753   .a 376 to 657 1 to 282       282/282
(100 %)
0 diff
(100 %id)
BF312372 brain, neuroblastoma .a 381 to 1155 1 to 774       774/989
(78 %)
29 diff
(97.1 %id)
BF313517 brain, neuroblastoma .a 381 to 1150 1 to 763       763/774
(98 %)
27 diff
(96.6 %id)
BI334955 cervical carcinoma cell line, cervix .a 381 to 1174 1 to 797       797/798
(99 %)
12 diff
(98.5 %id)
BC007846 Brain, neuroblastoma .a 382 to 2250 1 to 1869   available from MGC, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 1869/1869
(100 %)
1 diff
(100.0 %id)
CN299572 embryonic stem cells, DMSO-treated H9 cellline .a 382 to 752 1 to 371       371/371
(100 %)
0 diff
(100 %id)
AK027427   .a 395 to 2250 1 to 1856   available from FLJ,   1856/1856
(100 %)
2 diff
(99.9 %id)
DA489180 brain .a 396 to 952 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA782818 brain .a 401 to 971 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
AF199596   .a 404 to 1738 1 to 1335       1335/1335
(100 %)
6 diff
(99.6 %id)
AF226273   .a 404 to 1738 1 to 1335       1335/1335
(100 %)
2 diff
(99.9 %id)
CV027023 mixed .a 404 to 1055 1 to 652       652/652
(100 %)
4 diff
(99.4 %id)
TI_1948129394   .a 404 to 919 130 to 646       517/1281
(40 %)
14 diff
(99.0 %id)
TI_1948129742   .a 404 to 900 129 to 626       498/1142
(43 %)
12 diff
(99.0 %id)
TI_1948129743   .a 404 to 1147 128 to 872       745/1331
(55 %)
16 diff
(98.8 %id)
TI_1948130087   .a 404 to 1008 124 to 729       606/1369
(44 %)
9 diff
(99.4 %id)
TI_1948130427   .a 404 to 1019 126 to 740       615/1130
(54 %)
21 diff
(98.2 %id)
TI_1948130428   .a 404 to 1129 125 to 859       735/1414
(51 %)
24 diff
(98.4 %id)
TI_1948129395   .a 406 to 915 126 to 635       510/1338
(38 %)
11 diff
(99.2 %id)
BF835995 head_neck .a 415 to 905 507 to 13     Submitted on the opposite strand 495/525
(94 %)
7 diff
(98.7 %id)
BF838240 head_neck .a 415 to 905 507 to 13     Submitted on the opposite strand 495/525
(94 %)
7 diff
(98.7 %id)
BF835985 head_neck .a 450 to 905 482 to 26     Submitted on the opposite strand 457/482
(94 %)
1 diff
(99.8 %id)
BF838230 head_neck .a 450 to 905 482 to 26     Submitted on the opposite strand 457/482
(94 %)
1 diff
(99.8 %id)
BG825728 muscle, rhabdomyosarcoma .a 450 to 1147 124 to 839       795/849
(93 %)
41 diff
(95.2 %id)
BI115227 muscle, rhabdomyosarcoma .a 549 to 1166 1 to 612       612/612
(100 %)
10 diff
(98.4 %id)
DA425678 colon .a 617 to 1203 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
BG740495 skin .a 649 to 1457 1 to 810       810/812
(99 %)
2 diff
(99.8 %id)
BQ721755 dorsal root ganglia .a 697 to 1520 1 to 838       836/918
(91 %)
14 diff
(98.5 %id)
BI255298 cervical carcinoma cell line, cervix .a 712 to 1385 1 to 674       674/679
(99 %)
1 diff
(99.9 %id)
BI254452 cervical carcinoma cell line, cervix .a 737 to 1606 1 to 870       870/871
(99 %)
7 diff
(99.2 %id)
BM462137 eye, retinoblastoma .a 746 to 1794 1 to 1055       1053/1099
(95 %)
28 diff
(97.5 %id)
BG250501 adenocarcinoma, cell line, Liver .a 773 to 1460 1 to 688       688/689
(99 %)
1 diff
(99.9 %id)
TI_1948130429   .a 821 to 1737 1037 to 123       915/1315
(69 %)
26 diff
(98.1 %id)
TI_1948129744   .a 842 to 1737 1020 to 123       896/1346
(66 %)
26 diff
(98.1 %id)
W67716 heart .a 864 to 1299 1 to 436   fully sequenced,   436/436
(100 %)
5 diff
(98.9 %id)
TI_1948130088   .a 915 to 1737 948 to 112       837/1354
(61 %)
26 diff
(98.1 %id)
TI_1948130430   .a 929 to 1737 933 to 132       802/1107
(72 %)
18 diff
(98.4 %id)
BG113995 Bone, osteosarcoma, cell line .a 940 to 1693 1 to 753       753/872
(86 %)
12 diff
(98.7 %id)
TI_1948129745   .a 943 to 1737 916 to 126       791/1105
(71 %)
24 diff
(97.9 %id)
EC442823 Prostate .a 991 to 1084 1 to 93       93/102
(91 %)
1 diff
(99.1 %id)
EC491410 Prostate .a 991 to 1084 1 to 91       91/101
(90 %)
2 diff
(98.1 %id)
DA782831 brain .a 993 to 1575 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
TI_1948129397   .a 1017 to 1737 839 to 128       712/1053
(67 %)
28 diff
(97.4 %id)
TI_1948130089   .a 1017 to 1737 846 to 126       721/1095
(65 %)
8 diff
(99.3 %id)
BX336197 Placenta Cot 25-normalized .a 1035 to 1844 806 to 1   fully sequenced,   806/806
(100 %)
7 diff
(99.2 %id)
TI_1948129396   .a 1080 to 1737 784 to 123       662/1360
(48 %)
29 diff
(97.9 %id)
BY994726   .a 1086 to 1744 22 to 680       657/680
(96 %)
6 diff
(99.2 %id)
CN299580 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1098 to 1650 1 to 553       553/553
(100 %)
0 diff
(100 %id)
W68175 heart .a 1117 to 1286 393 to 224   fully sequenced,   170/393
(43 %)
0 diff
(100 %id)
BI253447 cervical carcinoma cell line, cervix .a 1122 to 1788 1 to 667       667/667
(100 %)
0 diff
(100 %id)
EC456786 Prostate .a 1132 to 1233 109 to 9       101/109
(92 %)
1 diff
(99.1 %id)
EC572028 Prostate .a 1132 to 1239 108 to 1       108/108
(100 %)
0 diff
(100 %id)
BG740099 skin .a 1138 to 1949 1 to 818       818/822
(99 %)
16 diff
(98.1 %id)
BM802169 duodenal adenocarcinoma, cell line, small intestine .a 1146 to 1925 1 to 790       790/917
(86 %)
14 diff
(98.5 %id)
DA455531 tongue, tumor tissue .a 1180 to 1747 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
BM710500 eye, RPE and Choroid .a 1188 to 1744 1 to 557       557/557
(100 %)
0 diff
(100 %id)
BM716358 eye, RPE and Choroid .a 1188 to 1588 1 to 402       402/402
(100 %)
1 diff
(99.8 %id)
T51720 fetal spleen, Spleen .a 1205 to 1560 1 to 367       367/385
(95 %)
17 diff
(95.6 %id)
DA772099 brain .a 1257 to 1834 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
AI985774 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 1287 to 1642 356 to 1       356/360
(98 %)
4 diff
(98.9 %id)
AA488546   .a 1298 to 1716 1 to 417   fully sequenced,   417/417
(100 %)
2 diff
(99.6 %id)
DA697513   .a 1302 to 1826 2 to 526   capped   525/525
(100 %)
0 diff
(100 %id)
BE019170 muscle, rhabdomyosarcoma .a 1316 to 1680 1 to 364       364/411
(88 %)
17 diff
(95.9 %id)
BE965542 epithelioid carcinoma, Pancreas .a 1338 to 1874 562 to 14   AAA   545/645
(84 %)
48 diff
(92.6 %id)
AA369496 placenta .a 1376 to 1571 1 to 196       196/196
(100 %)
1 diff
(99.5 %id)
CX788799 human embryonic stem cells .a 1380 to 2145 1 to 766       766/766
(100 %)
0 diff
(100 %id)
BY996064   .a 1383 to 2022 8 to 647       640/647
(98 %)
6 diff
(99.1 %id)
AA310580   .a 1396 to 1828 1 to 438       438/443
(98 %)
8 diff
(98.2 %id)
DA791746 brain .a 1436 to 1943 2 to 509   capped   508/508
(100 %)
0 diff
(100 %id)
C01909   .a 1445 to 1563 1 to 119       119/119
(100 %)
0 diff
(100 %id)
AL834479 melanoma (MeWo cell line) .a 1462 to 4518 1 to 3058   available from DKFZ, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 3058/3058
(100 %)
1 diff
(100.0 %id)
CX781832 human embryonic stem cells .a 1479 to 2250 798 to 27   AAA Submitted on the opposite strand 772/772
(100 %)
0 diff
(100 %id)
BF083018 colon_est .a 1531 to 1668 144 to 7       138/144
(95 %)
0 diff
(100 %id)
DA775714 brain .a 1561 to 2132 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
AF009767 lung, retina .a 1591 to 2252 635 to 1       597/635
(94 %)
27 diff
(95.8 %id)
BE300196 muscle, rhabdomyosarcoma .a 1604 to 2227 630 to 7       624/630
(99 %)
1 diff
(99.9 %id)
BF742188 breast .a 1613 to 2058 473 to 29     Submitted on the opposite strand 445/473
(94 %)
0 diff
(100 %id)
BM479783 embryonal carcinoma, cell line, testis .a 1613 to 2616 1 to 1012       1012/1018
(99 %)
35 diff
(96.6 %id)
DB193689 ovary, tumor tissue .a 1633 to 2212 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
AA488410   .a 1656 to 1871 216 to 1   fully sequenced,   216/216
(100 %)
0 diff
(100 %id)
AW247322.
matches multiple genes
lung, small cell carcinoma .a 1677 to 2260 584 to 1     also hits gene C12orf51 584/584
(100 %)
0 diff
(100 %id)
BJ991259 hepatoblastoma .a 1694 to 2233 540 to 1       540/540
(100 %)
1 diff
(99.9 %id)
DB184112 liver, tumor tissue .a 1694 to 2254 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA705937   .a 1726 to 2294 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
BE205767 muscle, rhabdomyosarcoma .a 1812 to 2252 441 to 1       441/441
(100 %)
0 diff
(100 %id)
DA257410 caudate nucleus .a 1834 to 2342 2 to 510   capped   509/509
(100 %)
0 diff
(100 %id)
AW733140 Kidney, renal cell adenocarcinoma .a 1867 to 2308 448 to 6       443/448
(98 %)
0 diff
(100 %id)
AW250460 lung, small cell carcinoma .a 1881 to 2260 380 to 1       380/380
(100 %)
2 diff
(99.5 %id)
DA665102   .a 1892 to 2405 2 to 515   capped   514/514
(100 %)
0 diff
(100 %id)
AA789061 bone marrow stroma .a 1893 to 2249 357 to 1       357/357
(100 %)
0 diff
(100 %id)
AI351586   .a 1936 to 2253 318 to 1       318/318
(100 %)
0 diff
(100 %id)
CB143399 Liver .a 1992 to 2250 288 to 30   AAA Submitted on the opposite strand 259/483
(53 %)
0 diff
(100 %id)
AA483161 Kidney .a 2007 to 2250 267 to 24   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 244/253
(96 %)
1 diff
(99.7 %id)
T35761 synovial membrane .a 2010 to 2250 1 to 241       241/241
(100 %)
0 diff
(100 %id)
CN344408 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2044 to 2663 1 to 620       620/620
(100 %)
0 diff
(100 %id)
BP253125 Kidney .a 2077 to 2659 1 to 583       583/583
(100 %)
0 diff
(100 %id)
AF035284 brain .a 2166 to 3938 1 to 1781   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 1781/1781
(100 %)
5 diff
(99.8 %id)
F05641 brain, total brain .a 2166 to 2364 1 to 205       205/205
(100 %)
4 diff
(98.1 %id)
F13380 brain, total brain .a 2166 to 2488 1 to 330       330/330
(100 %)
4 diff
(98.8 %id)
F07283 brain, total brain .a 2166 to 2458 1 to 299       299/299
(100 %)
5 diff
(98.4 %id)
H15474 whole brain .a 2167 to 2656 1 to 504       504/504
(100 %)
10 diff
(98.1 %id)
R12156 whole brain .a 2168 to 2639 1 to 479       479/480
(99 %)
7 diff
(98.6 %id)
BU184135 eye, retinoblastoma .a 2236 to 3141 1 to 909       909/909
(100 %)
11 diff
(98.8 %id)
AU132398   .a 2256 to 3021 2 to 767   capped   766/771
(99 %)
5 diff
(99.4 %id)
AW675367 cervical carcinoma cell line, cervix .a 2272 to 2685 1 to 414       414/414
(100 %)
0 diff
(100 %id)
AA489509   .a 2313 to 2444 1 to 132       132/132
(100 %)
0 diff
(100 %id)
BX329406 Neuroblastoma Cot 25-normalized .a 2314 to 2878 592 to 22       571/676
(84 %)
0 diff
(100 %id)
TI_154154588   .a 2320 to 2979 80 to 733       654/655
(99 %)
17 diff
(97.5 %id)
BM701394 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 2326 to 2577 1 to 252       252/252
(100 %)
0 diff
(100 %id)
BM717192 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 2326 to 2904 1 to 579       579/601
(96 %)
5 diff
(99.2 %id)
BP254923 Kidney .a 2346 to 2977 1 to 632       632/632
(100 %)
0 diff
(100 %id)
CN344407 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2352 to 2994 1 to 644       644/644
(100 %)
1 diff
(99.9 %id)
BU146766 brain, neuroblastoma, cell line .a 2353 to 3227 1 to 875       875/875
(100 %)
2 diff
(99.8 %id)
CX755480 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 2392 to 3102 1 to 711     Submitted on the opposite strand 711/715
(99 %)
4 diff
(99.5 %id)
DA090478 cerebellum .a 2408 to 3002 2 to 596   capped   595/595
(100 %)
0 diff
(100 %id)
CX870796 embryonic stem .a 2420 to 3215 7 to 802       796/802
(99 %)
0 diff
(100 %id)
BG698545 skin .a 2427 to 3078 28 to 670       643/670
(95 %)
6 diff
(99.2 %id)
AI681262 carcinoid, lung .a 2428 to 2890 464 to 1       464/464
(100 %)
1 diff
(99.8 %id)
BE252163 eye, retinoblastoma .a 2441 to 3056 1 to 616       616/616
(100 %)
2 diff
(99.7 %id)
BF969272 adrenal cortex carcinoma, cell line, adrenal gland .a 2518 to 3044 1 to 527       527/527
(100 %)
0 diff
(100 %id)
BU579967 insulinoma, Pancreas .a 2523 to 2914 1 to 392       392/392
(100 %)
4 diff
(99.0 %id)
CN344409 embryonic stem cells, DMSO-treated H9 cellline .a 2528 to 2717 1 to 190       190/190
(100 %)
0 diff
(100 %id)
BP265221 thyroid .a 2573 to 3152 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BQ880494 brain, neuroblastoma, cell line .a 2614 to 3544 1 to 933       933/935
(99 %)
24 diff
(97.5 %id)
CK902582 insulinoma, Pancreas .a 2628 to 2945 1 to 318       318/321
(99 %)
8 diff
(97.6 %id)
AL528624 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 2629 to 3421 1 to 789       789/959
(82 %)
37 diff
(96.2 %id)
CD244821 White Matter .a 2636 to 3515 1 to 885       885/892
(99 %)
14 diff
(98.5 %id)
DB575989 hypothalamus .a 2637 to 3111 1 to 475     Submitted on the opposite strand 475/476
(99 %)
1 diff
(99.8 %id)
CX786553 human embryonic stem cells .a 2661 to 3441 1 to 781       781/781
(100 %)
0 diff
(100 %id)
BQ946109 leiomyosarcoma, uterus .a 2693 to 3626 1 to 935       935/938
(99 %)
22 diff
(97.7 %id)
DA251734 caudate nucleus .a 2698 to 3273 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
CF242786 Brain glioblastoma .a 2708 to 3576 1 to 880       880/886
(99 %)
12 diff
(98.7 %id)
BI860812 breast, mammary adenocarcinoma, cell line .a 2727 to 3529 1 to 805       805/805
(100 %)
4 diff
(99.6 %id)
TI_57192416   .a 2727 to 3529 94 to 898       805/805
(100 %)
4 diff
(99.6 %id)
BQ437210 eye, retinoblastoma .a 2731 to 3517 1 to 796       796/868
(91 %)
13 diff
(98.6 %id)
CR738593   .a 2761 to 3250 1 to 490       490/490
(100 %)
0 diff
(100 %id)
CX867869 embryonic stem .a 2761 to 3575 1 to 815       815/815
(100 %)
0 diff
(100 %id)
BI256718 cervical carcinoma cell line, cervix .a 2785 to 3499 1 to 717       717/722
(99 %)
11 diff
(98.5 %id)
AA307348 colon .a 2792 to 3188 1 to 397       397/397
(100 %)
0 diff
(100 %id)
BG698266 skin .a 2792 to 3565 1 to 776       776/777
(99 %)
9 diff
(98.9 %id)
BG742072 skin .a 2802 to 3622 1 to 821       821/823
(99 %)
6 diff
(99.3 %id)
BM690785 eye, Retina Foveal and Macular .a 2818 to 3452 1 to 634     Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 634/637
(99 %)
4 diff
(99.4 %id)
BG253396 adenocarcinoma, cell line, Liver .a 2821 to 3525 1 to 703       703/1002
(70 %)
8 diff
(99.3 %id)
AF009757 lung, retina .a 2825 to 3094 270 to 1       270/272
(99 %)
5 diff
(98.2 %id)
BX096713 liver and spleen .a 2826 to 3583 1 to 760       760/760
(100 %)
4 diff
(99.5 %id)
AA083946   .a 2826 to 3188 1 to 363       363/364
(99 %)
1 diff
(99.8 %id)
CX164645 human embryonic stem cells differentiated toan early endodermal cell type .a 2833 to 3625 1 to 793       793/793
(100 %)
0 diff
(100 %id)
AA374100 lung .a 2834 to 3120 1 to 287       287/287
(100 %)
0 diff
(100 %id)
CB109300 Liver .a 2874 to 3395 1 to 522       522/522
(100 %)
0 diff
(100 %id)
AW893308 nervous_normal .a 2877 to 3303 434 to 10       425/434
(97 %)
0 diff
(100 %id)
TI_44344577   .a 2883 to 3468 86 to 672       587/672
(87 %)
6 diff
(99.2 %id)
DB501609 hypothalamus .a 2885 to 3363 1 to 479       479/480
(99 %)
2 diff
(99.6 %id)
DR761806 embryonic stem .a 2887 to 3685 1 to 799       799/799
(100 %)
2 diff
(99.8 %id)
CD624992   .a 2917 to 3338 426 to 3       424/431
(98 %)
0 diff
(100 %id)
CD624995   .a 2917 to 3338 426 to 3       424/431
(98 %)
0 diff
(100 %id)
BM845851 myeloma .a 2925 to 3309 1 to 385       385/385
(100 %)
0 diff
(100 %id)
TI_44345441   .a 2963 to 3696 88 to 816       729/816
(89 %)
6 diff
(99.3 %id)
AA314276 lung .a 2997 to 3251 1 to 255       255/255
(100 %)
0 diff
(100 %id)
CX752758 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 3009 to 3774 1 to 765     Submitted on the opposite strand 765/765
(100 %)
3 diff
(99.7 %id)
BP367408 thymus .a 3009 to 3587 1 to 581       581/581
(100 %)
27 diff
(95.4 %id)
DA001566   .a 3012 to 3573 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
AW960664   .a 3017 to 3594 1 to 575       575/576
(99 %)
3 diff
(99.5 %id)
CB120472 Liver .a 3020 to 3595 1 to 576       576/576
(100 %)
1 diff
(99.9 %id)
BG393064 embryonal carcinoma, cell line, testis .a 3027 to 3695 1 to 669       669/669
(100 %)
0 diff
(100 %id)
BG392836 embryonal carcinoma, cell line, testis .a 3027 to 3835 1 to 812       812/892
(91 %)
29 diff
(96.8 %id)
EC522420 Prostate .a 3036 to 3135 1 to 100       100/100
(100 %)
0 diff
(100 %id)
TI_149290518   .a 3047 to 3960 967 to 62       906/1072
(84 %)
0 diff
(100 %id)
DA038266   .a 3049 to 3618 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BF969608 adrenal cortex carcinoma, cell line, adrenal gland .a 3065 to 3861 1 to 787       787/943
(83 %)
27 diff
(97.2 %id)
BM802178 duodenal adenocarcinoma, cell line, small intestine .a 3089 to 3783 1 to 700       700/917
(76 %)
7 diff
(99.3 %id)
BG740784 skin .a 3090 to 3947 1 to 863       863/865
(99 %)
8 diff
(99.1 %id)
BU154300 eye, retinoblastoma .a 3102 to 3952 880 to 30     Submitted on the opposite strand 851/880
(96 %)
0 diff
(100 %id)
BG697473 skin .a 3103 to 3932 1 to 826       826/829
(99 %)
10 diff
(98.8 %id)
CN299576 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3104 to 3639 9 to 544       536/544
(98 %)
6 diff
(98.9 %id)
EC578445 Prostate .a 3117 to 3226 1 to 110       110/110
(100 %)
0 diff
(100 %id)
CN299563 embryonic stem cells, DMSO-treated H9 cellline .a 3123 to 3709 7 to 592       586/592
(98 %)
1 diff
(99.9 %id)
BE393342 endometrium, adenocarcinoma cell line, uterus .a 3142 to 3803 1 to 647       647/691
(93 %)
15 diff
(97.9 %id)
W81053 heart .a 3160 to 3644 1 to 485   fully sequenced,   485/485
(100 %)
1 diff
(99.8 %id)
BG674399 skin .a 3163 to 3947 1 to 785       785/792
(99 %)
8 diff
(99.0 %id)
BG742278 skin .a 3170 to 3933 1 to 764       764/764
(100 %)
2 diff
(99.8 %id)
BG740128 skin .a 3184 to 3864 1 to 679       679/679
(100 %)
3 diff
(99.6 %id)
BE789742 large cell carcinoma, lung .a 3197 to 3874 46 to 718       673/728
(92 %)
6 diff
(99.2 %id)
BE392323 endometrium, adenocarcinoma cell line, uterus .a 3201 to 3708 1 to 506       506/506
(100 %)
2 diff
(99.7 %id)
BI850461 Bone, osteosarcoma, cell line .a 3210 to 3939 1 to 721       721/729
(98 %)
5 diff
(99.4 %id)
BG028795 Bone, osteosarcoma, cell line .a 3211 to 3964 1 to 758       758/881
(86 %)
15 diff
(98.3 %id)
BF918759 nervous_tumor .a 3212 to 3688 512 to 34     Submitted on the opposite strand 479/512
(93 %)
0 diff
(100 %id)
CX867739 embryonic stem .a 3217 to 3968 1 to 751   fully sequenced, Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 751/751
(100 %)
1 diff
(99.9 %id)
AJ711734 heart .a 3218 to 3749 1 to 532       532/532
(100 %)
0 diff
(100 %id)
AW902076 nervous_normal .a 3237 to 3719 484 to 3       482/484
(99 %)
0 diff
(100 %id)
CN299561 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 3238 to 3905 1 to 668       668/668
(100 %)
0 diff
(100 %id)
F12173 brain, total brain .a 3240 to 3609 1 to 370       370/370
(100 %)
0 diff
(100 %id)
BG743105 skin .a 3241 to 4143 1 to 912       912/912
(100 %)
29 diff
(96.9 %id)
CN299573 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 3251 to 3935 1 to 685       685/685
(100 %)
0 diff
(100 %id)
CR602403 Placenta Cot 25-normalized .a 3251 to 4522 1 to 1272       1272/1272
(100 %)
0 diff
(100 %id)
BX380929 Placenta Cot 25-normalized .a 3251 to 4094 1 to 839       839/839
(100 %)
9 diff
(99.0 %id)
BE255347 eye, retinoblastoma .a 3260 to 3795 1 to 536       536/544
(98 %)
4 diff
(99.3 %id)
CB155583 brain .a 3262 to 3753 1 to 492       492/492
(100 %)
0 diff
(100 %id)
BM973498 lung .a 3263 to 3938 695 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 677/677
(100 %)
2 diff
(99.8 %id)
BG165911 hypernephroma, cell line, Kidney .a 3271 to 3938 12 to 684   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 673/684
(98 %)
6 diff
(99.2 %id)
BI850745 hypernephroma, cell line, Kidney .a 3275 to 3931 1 to 655       655/659
(99 %)
11 diff
(98.4 %id)
TI_154134125   .a 3275 to 3938 757 to 92   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 666/1156
(57 %)
23 diff
(98.1 %id)
AA600210 lung, lung carcinoma .a 3279 to 3683 1 to 405     Submitted on the opposite strand 405/405
(100 %)
0 diff
(100 %id)
AI742292 pooled .a 3313 to 3703 455 to 65       391/455
(85 %)
0 diff
(100 %id)
BG395627 eye, retinoblastoma .a 3328 to 3938 1 to 610   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 610/610
(100 %)
3 diff
(99.6 %id)
BG473863 eye, retinoblastoma .a 3328 to 3938 1 to 611   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 611/611
(100 %)
0 diff
(100 %id)
BG742921 skin .a 3332 to 4054 1 to 721       721/721
(100 %)
4 diff
(99.5 %id)
AI114741 Liver .a 3333 to 3952 624 to 5       620/624
(99 %)
0 diff
(100 %id)
AF271778   .a 3337 to 4518 86 to 1257   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 1172/1257
(93 %)
6 diff
(99.6 %id)
H15419 whole brain .a 3337 to 3946 620 to 1       620/623
(99 %)
36 diff
(94.3 %id)
AA160602 Pancreas .a 3337 to 3938 595 to 1       595/686
(86 %)
14 diff
(98.0 %id)
BE728622 melanotic melanoma, skin .a 3342 to 3938 1 to 598       598/598
(100 %)
2 diff
(99.7 %id)
AA057699 cornea .a 3380 to 3915 548 to 1       548/559
(98 %)
13 diff
(97.7 %id)
AW305118 brain, three pooled meningiomas .a 3385 to 3938 554 to 1       554/554
(100 %)
0 diff
(100 %id)
BP421163 small intestine .a 3394 to 3888 1 to 496     Submitted on the opposite strand 496/496
(100 %)
2 diff
(99.6 %id)
BF805610 colon_ins .a 3413 to 3697 307 to 27     Submitted on the opposite strand 281/307
(91 %)
0 diff
(100 %id)
BE388163 endometrium, adenocarcinoma cell line, uterus .a 3413 to 3937 1 to 523       523/523
(100 %)
3 diff
(99.5 %id)
EC579153 Prostate .a 3418 to 3520 1 to 99       99/99
(100 %)
4 diff
(96.0 %id)
AW576394 lymph .a 3425 to 3938 531 to 18   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 514/514
(100 %)
1 diff
(99.9 %id)
TI_149306425   .a 3431 to 3938 595 to 88   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 508/947
(53 %)
0 diff
(100 %id)
BU686461 lung, Primary Lung Epithelial Cells .a 3431 to 3938 526 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 508/516
(98 %)
0 diff
(100 %id)
AL563208 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 3446 to 4507 1046 to 1       1046/1127
(92 %)
27 diff
(97.7 %id)
AF009755 lung, retina .a 3450 to 3927 479 to 1       479/479
(100 %)
6 diff
(98.8 %id)
AA489510   .a 3453 to 3938 486 to 1       486/486
(100 %)
0 diff
(100 %id)
BU579721 insulinoma, Pancreas .a 3453 to 3938 502 to 17   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 486/486
(100 %)
0 diff
(100 %id)
DB568190 hypothalamus .a 3461 to 3938 1 to 478     Submitted on the opposite strand 478/478
(100 %)
0 diff
(100 %id)
DB573435 hypothalamus .a 3463 to 3938 1 to 476     Submitted on the opposite strand 476/476
(100 %)
0 diff
(100 %id)
AI497773 anaplastic oligodendroglioma, brain .a 3468 to 3938 471 to 1       471/471
(100 %)
1 diff
(99.8 %id)
AA778129 heart .a 3473 to 3939 467 to 1       467/467
(100 %)
1 diff
(99.8 %id)
AA365686 pineal body .a 3488 to 3776 1 to 289       289/289
(100 %)
0 diff
(100 %id)
AI087020 senescent fibroblast .a 3493 to 3951 459 to 1       459/459
(100 %)
0 diff
(100 %id)
DB560627 hypothalamus .a 3501 to 3938 1 to 440     Submitted on the opposite strand 440/440
(100 %)
3 diff
(99.4 %id)
DB557855 hypothalamus .a 3507 to 3936 1 to 431     Submitted on the opposite strand 431/433
(99 %)
13 diff
(97.0 %id)
BM663784 eye, Retina Foveal and Macular .a 3513 to 3938 443 to 18   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 426/426
(100 %)
1 diff
(99.8 %id)
BQ685459 ductal carcinoma, cell line, Pancreas .a 3554 to 4429 1 to 885       885/894
(98 %)
14 diff
(98.5 %id)
AW674760 cervical carcinoma cell line, cervix .a 3603 to 3941 339 to 1       339/339
(100 %)
0 diff
(100 %id)
W80802 heart .a 3614 to 3938 327 to 1   fully sequenced,   327/327
(100 %)
0 diff
(100 %id)
AA703446 liver and spleen .a 3620 to 3758 139 to 1       139/139
(100 %)
0 diff
(100 %id)
EC484652 Prostate .a 3627 to 3725 1 to 95       95/97
(97 %)
5 diff
(94.9 %id)
R15088 whole brain .a 3644 to 3946 299 to 1       299/299
(100 %)
11 diff
(96.4 %id)
F03555 brain, total brain .a 3653 to 3938 286 to 1       286/286
(100 %)
1 diff
(99.7 %id)
TI_57229833   .a 3655 to 4440 88 to 885       798/799
(99 %)
35 diff
(95.7 %id)
TI_149310085   .a 3665 to 4523 936 to 89   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 848/950
(89 %)
16 diff
(98.4 %id)
F10971 brain, total brain .a 3685 to 3938 254 to 1       254/256
(99 %)
0 diff
(100 %id)
TI_149305218   .a 3692 to 4518 917 to 92   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 826/984
(83 %)
15 diff
(98.5 %id)
BX330509 Placenta Cot 25-normalized .a 3705 to 4522 813 to 1       813/882
(92 %)
8 diff
(99.1 %id)
DB480193 hippocampus .a 3706 to 4193 1 to 488       488/488
(100 %)
3 diff
(99.4 %id)
TI_154127524   .a 3718 to 4518 887 to 92   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 796/946
(84 %)
9 diff
(99.1 %id)
BG105771 adrenal cortex carcinoma, cell line, adrenal gland .a 3733 to 4525 1 to 805       805/839
(95 %)
51 diff
(94.0 %id)
TI_154100871   .a 3751 to 4518 851 to 86   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 766/836
(91 %)
13 diff
(98.5 %id)
EC563059 Prostate .a 3754 to 3861 1 to 108       108/108
(100 %)
0 diff
(100 %id)
BU688385 lung .a 3764 to 4523 772 to 14   tiling clone, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 759/759
(100 %)
3 diff
(99.7 %id)
CN299567 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3801 to 4435 1 to 635       635/635
(100 %)
0 diff
(100 %id)
TI_149294121   .a 3817 to 4523 791 to 86   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 706/707
(99 %)
3 diff
(99.6 %id)
TI_149282064   .a 3825 to 4523 793 to 93   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 701/706
(99 %)
9 diff
(98.8 %id)
BX348917 Placenta Cot 25-normalized .a 3827 to 4521 1 to 691       691/691
(100 %)
5 diff
(99.3 %id)
BM984951 lung .a 3838 to 4523 699 to 14   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 686/686
(100 %)
2 diff
(99.8 %id)
BM983644 lung .a 3841 to 4523 696 to 14   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 683/683
(100 %)
4 diff
(99.5 %id)
BF155650 head_neck .a 3929 to 4443 560 to 35       526/561
(93 %)
0 diff
(100 %id)
CX867662 embryonic stem .a 3938 to 4518 605 to 26   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 580/580
(100 %)
4 diff
(99.4 %id)
AI565712 anaplastic oligodendroglioma, brain .a 3964 to 4518 555 to 1       555/555
(100 %)
0 diff
(100 %id)
BM692595 eye, human retina .a 3968 to 4502 1 to 536   fully sequenced, Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 536/536
(100 %)
3 diff
(99.5 %id)
TI_154037309   .a 3994 to 4523 618 to 89   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 530/782
(67 %)
4 diff
(99.5 %id)
EC531264 Prostate .a 4016 to 4120 1 to 105       105/105
(100 %)
0 diff
(100 %id)
AI052027 parathyroid gland, parathyroid tumor .a 4022 to 4523 515 to 14   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 502/502
(100 %)
0 diff
(100 %id)
AW513386 colon, juvenile granulosa tumor .a 4038 to 4518 481 to 1       481/481
(100 %)
0 diff
(100 %id)
EC485799 Prostate .a 4042 to 4142 1 to 101       101/101
(100 %)
0 diff
(100 %id)
EC544500 Prostate .a 4042 to 4142 1 to 101       101/101
(100 %)
0 diff
(100 %id)
AW130360 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 4048 to 4524 478 to 2       477/478
(99 %)
0 diff
(100 %id)
AA236623 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 4049 to 4276 1 to 227   fully sequenced,   227/227
(100 %)
1 diff
(99.6 %id)
DB552567 hippocampus .a 4054 to 4523 1 to 470     Submitted on the opposite strand 470/470
(100 %)
0 diff
(100 %id)
DB572809 hypothalamus .a 4054 to 4518 1 to 465     Submitted on the opposite strand 465/465
(100 %)
0 diff
(100 %id)
DB548783 hippocampus .a 4063 to 4518 1 to 456     Submitted on the opposite strand 456/456
(100 %)
0 diff
(100 %id)
DB548934 hippocampus .a 4063 to 4518 1 to 456     Submitted on the opposite strand 456/456
(100 %)
0 diff
(100 %id)
AI094889 brain, glioblastoma (pooled) .a 4066 to 4520 455 to 1       455/455
(100 %)
0 diff
(100 %id)
DB525530 testis .a 4077 to 4518 1 to 442     Submitted on the opposite strand 442/442
(100 %)
0 diff
(100 %id)
AI384060 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 4082 to 4520 439 to 1       439/439
(100 %)
0 diff
(100 %id)
DB559168 hypothalamus .a 4108 to 4518 1 to 411     Submitted on the opposite strand 411/411
(100 %)
0 diff
(100 %id)
BE222996 brain, oligodendroglioma .a 4108 to 4518 426 to 16   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 411/411
(100 %)
0 diff
(100 %id)
AF009756 lung, retina .a 4110 to 4518 410 to 2       409/410
(99 %)
0 diff
(100 %id)
AI028790   .a 4110 to 4524 419 to 5       415/419
(99 %)
0 diff
(100 %id)
AI356127 brain, glioblastoma (pooled) .a 4116 to 4519 404 to 1       404/404
(100 %)
0 diff
(100 %id)
AA083858   .a 4121 to 4519 399 to 1       399/399
(100 %)
2 diff
(99.5 %id)
AI239724 pooled .a 4138 to 4518 393 to 13   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 381/381
(100 %)
0 diff
(100 %id)
BM692992 eye, Retina Foveal and Macular .a 4163 to 4518 1 to 356   fully sequenced, Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 356/356
(100 %)
1 diff
(99.8 %id)
AW263220 pooled .a 4191 to 4521 331 to 1       331/331
(100 %)
0 diff
(100 %id)
AW016192   .a 4202 to 4518 334 to 18   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 317/317
(100 %)
0 diff
(100 %id)
DB369401   .a 4211 to 4515 308 to 4       305/308
(99 %)
0 diff
(100 %id)
BM663817 eye, human retina .a 4217 to 4517 320 to 20   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 301/301
(100 %)
0 diff
(100 %id)
AI918300 anaplastic oligodendroglioma, brain .a 4224 to 4518 295 to 1       295/295
(100 %)
0 diff
(100 %id)
AI422577 Prostate .a 4225 to 4518 294 to 1       294/294
(100 %)
0 diff
(100 %id)
F09805 brain, total brain .a 4227 to 4518 293 to 1       293/293
(100 %)
1 diff
(99.7 %id)
AA236999 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 4246 to 4520 274 to 1   fully sequenced,   274/274
(100 %)
0 diff
(100 %id)
AI474974 anaplastic oligodendroglioma, brain .a 4285 to 4519 235 to 1       235/235
(100 %)
0 diff
(100 %id)
T74198 Liver .a 4305 to 4519 1 to 215   fully sequenced,   215/215
(100 %)
2 diff
(99.1 %id)
BM668341 eye, Retina Foveal and Macular .a 4325 to 4523 212 to 14   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 199/199
(100 %)
0 diff
(100 %id)
BM969580 lung, Primary Lung Epithelial Cells .a 4336 to 4518 201 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 183/183
(100 %)
0 diff
(100 %id)
EH341137   .a 4339 to 4398 1 to 61       61/65
(93 %)
2 diff
(97.0 %id)
GD136211   .a 4339 to 4522 1 to 184       184/195
(94 %)
2 diff
(99.0 %id)
T74199 Liver .a 4440 to 4517 77 to 1   fully sequenced,   77/77
(100 %)
0 diff
(100 %id)
DA735043   .b 1 to 563 15 to 576   tiling clone, capped   562/565
(99 %)
7 diff
(98.8 %id)
BG749105 eye, normal pigmented retinal epithelium .b 21 to 837 1 to 820   tiling clone,   820/939
(87 %)
18 diff
(98.1 %id)
DB367214   .b 1329 to 1863 535 to 1   tiling clone,   535/537
(99 %)
10 diff
(98.2 %id)
DA351102 substantia nigra .c 1 to 559 2 to 560   tiling clone, capped   559/559
(100 %)
0 diff
(100 %id)
DB310364 substantia nigra .c 1498 to 2011 514 to 1   tiling clone,   514/514
(100 %)
2 diff
(99.7 %id)
DA157065 amygdala .c 1501 to 2004 2 to 505   capped   504/504
(100 %)
0 diff
(100 %id)
AI754431 bone marrow stroma .c 1505 to 2011 525 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 507/507
(100 %)
0 diff
(100 %id)
DB577033 hypothalamus .c 1521 to 2011 1 to 491     Submitted on the opposite strand 491/491
(100 %)
0 diff
(100 %id)
DB540702 hippocampus .c 1526 to 2011 1 to 486     Submitted on the opposite strand 486/486
(100 %)
0 diff
(100 %id)
DB541841 hippocampus .c 1540 to 2009 1 to 469     Submitted on the opposite strand 469/471
(99 %)
2 diff
(99.6 %id)
CV362029 nervous_normal .c 1599 to 1985 25 to 412       388/426
(91 %)
7 diff
(98.4 %id)
AA613790   .c 1626 to 1877 251 to 1       251/251
(100 %)
1 diff
(99.7 %id)
BE383180 brain, neuroblastoma .d 1 to 680 1 to 675   tiling clone,   671/719
(93 %)
12 diff
(98.4 %id)
DA684030   .d 18 to 536 2 to 520   capped   519/519
(100 %)
0 diff
(100 %id)
DA059522 cerebellum .d 24 to 568 2 to 550   capped   545/549
(99 %)
1 diff
(99.9 %id)
DA831239 placenta .d 33 to 725 2 to 695   tiling clone, capped   694/768
(90 %)
5 diff
(99.4 %id)
DB376798 placenta .d 1386 to 1828 445 to 1   tiling clone,   445/456
(97 %)
14 diff
(97.0 %id)
DC389538 Spleen .e 1 to 493 1 to 493   tiling clone,   493/493
(100 %)
3 diff
(99.4 %id)
AK298871   .e 175 to 1725 1 to 1551 F244Y tiling clone,   1551/1551
(100 %)
2 diff
(99.9 %id)
DC366622   .e 175 to 723 1 to 549       549/549
(100 %)
1 diff
(99.9 %id)
AK289552 cerebellum .f 1 to 1690 1 to 1690 exact tiling clone,   1690/1690
(100 %)
2 diff
(99.9 %id)
DA114919 cerebellum .f 2 to 548 2 to 549   capped   548/552
(99 %)
2 diff
(99.7 %id)
BP377078 uterus .g 1 to 583 1 to 581   tiling clone,   581/583
(99 %)
8 diff
(98.7 %id)
CB144975 Liver .g 165 to 516 1 to 352       352/352
(100 %)
0 diff
(100 %id)
CX763104 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .g 170 to 701 1 to 532   tiling clone, Submitted on the opposite strand 532/788
(67 %)
7 diff
(99.2 %id)
BM479409 eye, retinoblastoma .h 1 to 926 7 to 938 exact tiling clone,   932/1000
(93 %)
21 diff
(97.9 %id)
DA130118 alzheimer cortex .i 1 to 639 2 to 640   tiling clone, capped   639/639
(100 %)
7 diff
(99.0 %id)
BG674846 skin .i 166 to 938 1 to 773 A125Q S126L W127V W128E N129T ... tiling clone,   772/794
(97 %)
22 diff
(97.3 %id)
BP332647 renal proximal tubule .j 1 to 582 1 to 582 exact tiling clone,   582/582
(100 %)
0 diff
(100 %id)
BP332683 renal proximal tubule .j 1 to 582 1 to 582 T9P     582/582
(100 %)
1 diff
(99.9 %id)
BP264519 umbilical vein .k 1 to 567 1 to 567 S8C G11V S28G P94L tiling clone,   567/567
(100 %)
6 diff
(99.0 %id)
DA739030   .l 1 to 544 2 to 546 S56L R57P V58G I59H S60Q ... tiling clone, capped   545/545
(100 %)
2 diff
(99.7 %id)
BP315843 mammary gland .m 1 to 581 1 to 581 K107X tiling clone,   581/581
(100 %)
1 diff
(99.9 %id)
DB369023   .n 1 to 473 1 to 471 T2M W41X L77X F84X L89X tiling clone, Submitted on the opposite strand 471/471
(100 %)
6 diff
(98.8 %id)
BU183462 melanotic melanoma, cell line, skin .o 1 to 811 1 to 820 exact tiling clone,   820/952
(86 %)
22 diff
(97.7 %id)
BQ684351 melanotic melanoma, cell line, skin .o 1 to 509 1 to 510 exact     510/1035
(49 %)
15 diff
(98.6 %id)
BQ681035 melanotic melanoma, cell line, skin .o 1 to 697 1 to 697 exact     697/948
(73 %)
5 diff
(99.5 %id)
BQ684405 melanotic melanoma, cell line, skin .o 1 to 686 1 to 686 exact     686/882
(77 %)
24 diff
(97.3 %id)
CB960611 Human Placenta, placenta .o 47 to 777 26 to 768   tiling clone,   743/794
(93 %)
13 diff
(98.4 %id)
AI760736 B-cell, chronic lymphotic leukemia .o 293 to 760 1 to 468   tiling clone, Submitted on the opposite strand 468/468
(100 %)
0 diff
(100 %id)
BE894186 melanotic melanoma, skin .p 1 to 667 1 to 681   tiling clone,   681/788
(86 %)
25 diff
(96.9 %id)
DA916467 small intestine .p 437 to 1009 2 to 574 exact tiling clone, to resequence, capped   573/573
(100 %)
4 diff
(99.4 %id)
DB331700 small intestine .p 1683 to 2235 553 to 1   tiling clone, to resequence,   553/553
(100 %)
0 diff
(100 %id)
DA937449 Spleen .q 1 to 579 2 to 582 R43D P44R L45C P46L W47G ... tiling clone, capped   581/581
(100 %)
17 diff
(97.1 %id)
DB079146 testis .r 1 to 562 2 to 563 exact tiling clone, capped   562/562
(100 %)
0 diff
(100 %id)
AV701847 adrenal gland Gene FADS1, variant not shown         Suspected internal deletion, this clone was ignored    
AV707746 adrenal gland Gene FADS1, variant not shown         Suspected internal deletion, this clone was ignored    
AV709144 adrenal gland Gene FADS1, variant not shown         Suspected internal deletion, this clone was ignored    
AK096275   Gene FADS1, variant not shown       available from FLJ, This clone was ignored    
BF768669 epid_tumor Gene FADS1, variant not shown              
DB309496 hippocampus Gene FADS1, variant not shown         This clone was ignored    
DA328375 hippocampus Gene FADS1, variant not shown       capped This clone was ignored    
BP210583 cerebellum Gene FADS1, variant not shown         Suspected internal deletion, this clone was ignored    
BX399611 Placenta Cot 25-normalized Gene FADS1, variant not shown         Suspected internal deletion, this clone was ignored    
BX399612 Placenta Cot 25-normalized Gene FADS1, variant not shown         Suspected internal deletion, this clone was ignored    
EC448403 Prostate Gene FADS1, variant not shown         This clone was ignored    
DB317525 brain Gene FADS1, variant not shown              
DA527496 brain Gene FADS1, variant not shown       capped      
DB502227 hypothalamus Gene FADS1, variant not shown         Suspected internal deletion, this clone was ignored    
H99857.
matches multiple genes
melanocyte Gene FADS1, variant not shown         This clone was ignored, also hits gene blerplo    
H99857.
matches multiple genes
melanocyte Gene blerplo, variant not shown         This clone was ignored, also hits gene blerplo    
N28538.
matches multiple genes
melanocyte Gene FADS1, variant not shown         This clone was ignored, also hits gene blerplo    
N28538.
matches multiple genes
melanocyte Gene blerplo, variant not shown         This clone was ignored, also hits gene blerplo    
H49261 liver and spleen Gene FADS1, variant not shown         This clone was ignored    
H49262 liver and spleen Gene FADS1, variant not shown         This clone was ignored    
BE271822 adenocarcinoma cell line, ovary Gene FADS1, variant not shown         This clone was ignored    
BM475271 eye, retinoblastoma Gene FADS1, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BU859220 ovary, teratocarcinoma, cell line Gene FADS1, variant not shown         This clone was ignored    
TI_154126433   Gene FADS1, variant not shown         This clone was ignored    
CA416571 Chondrosarcoma Cell line Gene FADS1, variant not shown       AAA This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI